Berthold Seitz
Ophthalmology — Universitätsklinikum des Saarlandes, Germany
Berthold Seitz
LeadR Profile
Ophthalmology
Subspecialties: Surgery - Biochemistry - Otolaryngology
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 1996 - 2026
Number : 1181
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| [The eye as a mirror of the heart-retinal findings in heart failure and cardiovascular diseases]. microcirculation, retina, heart failure, heart, cardiovascular diseases, vascular diseases, retinaldehyde, geriatrics | Z Gerontol Geriatr | 2026 | 0 |
| Sex-Specific Differences in Corneal Remodeling after Descemet Membrane Endothelial Keratoplasty in Fuchs Endothelial Corneal Dystrophy. eye, cells, fuchs' endothelial dystrophy, corneal transplantation, corneal dystrophies, hereditary, visual acuity, descemet membrane, sex, membranes | Ophthalmol Sci | 2026 | 0 |
| Patterns of Choroidal Configuration in Pachychoroid Spectrum Disease. eye, choroidal neovascularization, choroid, veins | Ophthalmol Sci | 2026 | 0 |
| Advances in diagnostic training for retinopathy of prematurity with the introduction of the Eyesi Indirect Ophthalmoscope ROP Simulator: an exploratory study to assess its construct and face validity. classification, ophthalmoscopes, retinopathy of prematurity | J AAPOS | 2026 | 0 |
| Custom bipolar electrode for bleomycin-based electrochemotherapy in patient-derived uveal melanoma in ovo and ex vivo. cells, bleomycin, melanoma, neoplasms, electrodes, electrochemotherapy, transplants, therapeutics, cell death, uveal melanoma | Front Cell Dev Biol | 2026 | 0 |
Clinical Studies 13
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| An efficacy and safety study of cenegermin ophthalmic solution compared with vehicle in the treatment of PCED 2025-523443-35-00 — eye, growth, safety, solutions, nerve growth factor, ophthalmic solutions, therapeutics, pharmaceutical vehicles | Phase 3 | Recruiting | 2026 |
| Pretreatment to Promote Graft Survival After Subsequent High risk Corneal Transplantation CrossCornealVision NCT05870566 — cells, safety, microscopy, electron, scanning transmission, corneal transplantation, vitamins, ultraviolet rays, cornea, stem cells, graft survival, lymph, flavin mononucleotide, transplants, therapeutics, debridement, riboflavin, transplantation | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map